Install
- 77articles · 30d
- 12+ hour agolatest article
- Aug 16, 2026earliest in window
- 100%with images
- 291avg words
- Economy, Business & Finance 69
- Finance & Business 69
- News 46
- Finance 23
- Politics 5
- Business & Industrial 4
- Politics2 4
- Conflict, War & Peace 2
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Why is Elevance Health stock surging today? By Investing.com
3+ day, 21+ hour ago (302+ words) Updated Sep 10, 2026 01:13PM ET Investing.com -- Elevance Health stock surged 5.8% in mid-day trading to reach $418.21 after the company issued a Regulation FD disclosure through a Form 8-K filing, reaffirming its full-year 2026 adjusted earnings guidance of at least $27.00 per diluted share. In…...
Why is Nebius stock sliding today? By Investing.com
4+ day, 6+ min ago (322+ words) Why is Nebius stock sliding today? Investing.com | Editor Vlad Schepkov Published Dec 31, 0000 07:00PM ET Updated Sep 10, 2026 10:16AM ET Investing.com -- Shares of Nebius fell 4.2% in morning trading after CEO Arkady Volozh’s appearance at Citi’s 2026 Global TMT Conference on Wednesday reignited investor…...
Piper Sandler initiates Intel stock coverage at Neutral on valuation By Investing.com
4+ day, 4+ hour ago (215+ words) Updated Sep 10, 2026 06:28AM ET Investing.com - Piper Sandler initiated coverage on Intel Corp. (NASDAQ:INTC) with a Neutral rating and a price target of $110.00, the firm said Wednesday. The stock currently trades at $106.24, reflecting a remarkable 328% gain over the past year…...
MercadoLibre stock falls as company taps debt markets By Investing.com
5+ day, 15+ min ago (134+ words) Updated Sep 09, 2026 10:29AM ET Investing.com -- MercadoLibre Inc (NASDAQ:MELI) shares fell 2.8% Wednesday after Bloomberg reported the company is returning to global debt markets for only the third time. The regional e-commerce and fintech giant is offering dollar notes maturing in…...
Why is Boston Scientific stock sliding today? By Investing.com
6+ day, 3+ hour ago (339+ words) Updated Sep 08, 2026 06:47AM ET Investing.com -- Boston Scientific stock fell 2.3% in pre-open trading after the company formally warned that the cyberattack discovered on August 25 is now expected to have a material impact on its third-quarter and full-year 2026 results, with the company…...
Why is Roivant Sciences stock surging today? By Investing.com
6+ day, 4+ hour ago (316+ words) Updated Sep 08, 2026 06:26AM ET Investing.com -- Roivant Sciences stock surged 22.0% in pre-open trading after its Pulmovant subsidiary unveiled positive topline results from the Phase 2 PHocus study of mosliciguat in patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD), a progressive…...
Rothschild Redburn initiates Guardant Health stock with buy rating By Investing.com
6+ day, 6+ hour ago (194+ words) Updated Sep 08, 2026 04:12AM ET Investing.com - Rothschild Redburn initiated coverage on Guardant Health Inc. (NASDAQ:GH) with a Buy rating and set a price target of $203.00. The stock currently trades at $161.41, up 168% over the past year, though InvestingPro analysis suggests the…...
Why is Aeroports de Paris stock rallying today? By Investing.com
6+ day, 6+ hour ago (302+ words) Updated Sep 08, 2026 04:10AM ET Investing.com -- Aeroports de Paris SA stock rose 2.2% to trade at €110.6 after JPMorgan upgraded the company from Neutral to Overweight and lifted its price target to EUR 130, up from EUR 115, pointing to the emerging regulatory framework as…...
Why is Lottomatica stock surging today? By Investing.com
1+ week, 4+ hour ago (222+ words) Updated Sep 07, 2026 06:33AM ET The additional detail proved pivotal in rehabilitating investor sentiment. The original Cirsa merger announcement had triggered a steep selloff, as markets reacted negatively to the dilutive nature of an all-stock deal and uncertainty over integration economics. Today’s…...
Eli Lilly’s $100B incretin opportunity: Is more upside coming? By Investing.com
1+ week, 17+ hour ago (415+ words) Updated Sep 06, 2026 05:19PM ET Investing.com -- Eli Lilly & Co is positioned for further growth in the booming obesity-drug market, with its Zepbound and Mounjaro treatments and a pipeline of next-generation therapies offering multiple avenues for upside, J.P. Morgan said in a research…...